Reliance, Capri Global to acquire Mumbai’s SevenHills Hospital

Reliance Industries and Capri Global will acquire Mumbai’s 1,500-bed SevenHills Hospital, ending an eight-year impasse. The hospital will be converted into a not-for-profit entity, with funds infused via equity support.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jyVMDnm
via IFTTT

Read More

Drug misuse: Govt may curb 'Pregabalin' sales

The government is looking to control the sale of Pregabalin. This common medicine is being misused. The government wants to make sure it is only sold with a doctor's prescription. This move follows concerns raised by authorities. Pregabalin is used for pain and seizures. Stricter rules are being considered to prevent its misuse.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eR6UohJ
via IFTTT

Read More

S&P Global upgrades Biocon Biologics credit rating To 'BB+'

Biocon Biologics has received a credit rating upgrade from S&P Global Ratings. The company's long-term issuer credit rating is now 'BB+' with a stable outlook. This upgrade follows Biocon's simplification of its capital structure and reduction of debt. New product launches and industry trends are expected to support Biocon's earnings growth in the coming years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EBvlO6z
via IFTTT

Read More

India-EU trade deal: A tonic for pharma companies

India and the EU are set to eliminate tariffs on pharmaceutical products, a move expected to significantly benefit India's pharma industry by reducing input costs and improving access to advanced medicines. Experts believe this will enhance trade and collaboration, strengthening India's position in the EU market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HQSgTiI
via IFTTT

Read More

India's over-the-counter drugs market to hit Rs 98,000 crore by 2030: Report

An EY report estimated that India's OTC market, valued around Rs 47,000 crore in 2024, is projected to grow to Rs 98,000 crore around 13 per cent CAGR through 2030.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cAKW5PH
via IFTTT

Read More

India-EU FTA to strengthen position of Indian formulations, medicines in EU

A new India-EU free trade agreement promises to boost Indian pharmaceutical exports. Lower tariffs will make Indian medicines more competitive in Europe. This deal also aims to improve access to affordable, high-quality medicines for Indian patients. Experts anticipate significant price reductions for advanced therapies in the coming years. The agreement strengthens trade and collaboration between the two regions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MNICFpz
via IFTTT

Read More

PRISM-PCI Conclave 2026 in Vapi highlights India’s evolving approach to heart care

The PRISM-PCI Conclave 2026 highlighted India's significant advancements in cardiac care, showcasing its evolution from a consumer to a contributor in medical technology innovation. The event emphasized precision-driven strategies and the growing role of home-grown technologies in addressing complex cardiovascular diseases, improving patient outcomes globally.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/noeyFjI
via IFTTT

Read More